Investment area
Growth Investments
Planetary Health Investments
Region
North America
Date of investment
November 2019
bioMASON, Inc. is a unique biomaterials startup whose technology provides a better solution for reducing the CO2 emissions generated by global masonry manufacturing.
Contact
Anders Bendsen Spohr
Senior Partner, Head of Planetary Health Investments
Departments: Life Sciences Operating Committee, Planetary Health Investments
Anders joined Novo Holdings A/S in 2017.
Anders is Sr Partner and Head of the Planetary Health Investments team.
Prior to joining Novo Holdings, Anders was employed as VP in Xellia Pharmaceuticals heading up the Global Product Supply. Other previous employments include EVP, Global Product Supply at Leo Pharma A/S and VP Global Supply Chain at Novozymes A/S.
Anders holds a PhD in Biotechnology and a MSc in Chemical Engineering from Technical University of Denmark as well as a graduate diploma in Business Administration (International Business) from Copenhagen Business School.
